在生殖线ATM突变黑色素瘤中评估对PARP抑制反应的决定因素
Eleonora Allavena1,2, Michela Croce3, Bruna Dalmasso2
1Department of Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, Italy.
International journal of molecular sciences
|August 14, 2025
概括
有害的ATM变体和同源重组缺陷 (HRD) 并没有预测黑色素瘤中PARP抑制剂 (PARPi) 敏感性. 沉默SLFN11有助于耐药性,这表明需要全面的方法来有效治疗黑色素瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 这种阿塔克西亚 - 泰朗吉克塔西亚 - 突变 (ATM) 蛋白质对于DNA损伤反应和同源重组 (HR) 是至关重要的.
- 亚太流动机变体可能导致同源重组缺陷 (HRD),这是PARP抑制剂 (PARPi) 的目标.
- 黑色素瘤治疗的有效性可能有所不同,因此需要对抗性机制有更深入的了解.
研究的目的:
- 调查生殖线ATM变异对黑色素瘤HRD和PARPi反应的影响.
- 探索SLFN11表达在ATM突变黑色素瘤中PARPi耐药性的作用.
- 评估将ATR抑制剂 (ATRi) 与PARPi结合的潜力.
主要方法:
- 从一个患有生殖系ATM变体 (c.5979_5983del) 的患者中建立了一种黑色素瘤细胞系.
- 评估了HRD,ATM激活,SLFN11表达和促进物甲基化.
- 测试了对PARPi,ATRi和组合疗法的敏感性.
主要成果:
- 该ATM突变细胞系表现出HRD,但缺乏对PARPi的敏感性.
- 由于高甲基化介导促进体沉默,SLFN11表达不存在.
- 虽然对ATRi敏感,但ATRi和PARPi的组合无法克服PARPi的耐药性.
结论:
- 仅仅ATM突变状态和HRD不足以预测PARPi在这种黑色素瘤模型中的反应.
- 沉默SLFN11是PARPi电阻的一个潜在机制.
- 为了优化针对黑色素瘤患者的DNA修复缺陷向治疗,需要一个多方面的策略.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Long-patch Base Excision Repair
7.2K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


